Bota Biosciences Funding: $145M Raised, Series B+ (2024)
Bota Biosciences is based in Boston, Massachusetts. It has raised $145M in total funding. Latest round: Series B+.
Bota Biosciences funding overview
Bota Biosciences is based in Boston, Massachusetts. Bota Biosciences has raised $145M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B+ announced in June 2024. The round record for Bota Biosciences runs through 2024; nothing later has been disclosed. Investors on record include BASF Ventures, Sequoia Capital China, Matrix Partners China, Source Code Capital, Sherpa Healthcare Partners, 5Y Capital and 4 others. 10 distinct backers are named across the disclosed rounds.
Bota Biosciences at a glance
Total raised
$145M
Latest round
Series B+
Latest round date
June 2024
Headquarters
Boston, Massachusetts
Notable investors
BASF Ventures, Sequoia Capital China, Matrix Partners China, Source Code Capital, Sherpa Healthcare Partners, 5Y Capital, Meituan, IDG Capital
Frequently asked about Bota Biosciences funding
How much has Bota Biosciences raised?
Bota Biosciences has raised $145M in total disclosed funding across the rounds on record.
Who has invested in Bota Biosciences?
BASF Ventures, Sequoia Capital China, Matrix Partners China, Source Code Capital, Sherpa Healthcare Partners, 5Y Capital are named among the investors backing Bota Biosciences.
What was the latest Bota Biosciences funding round?
The most recent disclosed round is a Series B+, announced in June 2024.
Where is Bota Biosciences based?
Bota Biosciences is based in Boston, Massachusetts.
When did Bota Biosciences last raise?
The last disclosed Bota Biosciences round closed in June 2024 at Series B+.
Every Bota Biosciences figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Boston at a similar stage.
